Literature DB >> 16594904

Mechanotransduction and the homeostatic significance of maintaining blood viscosity in hypotension, hypertension and haemorrhage.

J Martini1, P Cabrales, A G Tsai, M Intaglietta.   

Abstract

The increase of plasma and blood viscosity is usually associated with pathological conditions; however, elevation of both parameters often results in increased perfusion and the lowering of peripheral vascular resistance. In extreme haemodilution, blood viscosity is too low and insufficient to maintain functional capillary density, a problem that in experimental studies is shown to be corrected by increasing plasma viscosity up to 2.2 cP. This effect is mediated by mechanotransduction-induced nitric oxide (NO) production via shear stress in the endothelium as shown by microelectrode perivascular measurements of NO concentration. Moderate elevations of blood viscosity by increasing haematocrit ( approximately 10%) result in comparable reductions of blood pressure and peripheral vascular resistance, an effect also NO-mediated as it is absent after Nomega-nitro-L-arginine methyl ester treatment and in endothelial nitric oxide synthase-deficient mice. These findings show that the rheological properties of plasma affect vessel diameter in the microcirculation leading to counterintuitive responses to the changes in blood and plasma viscosity. Application of these findings to haemorrhagic shock resuscitation leads to the concept of hyperosmotic-hyperviscous resuscitation as a modality for maintaining the recovery of microvascular function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16594904     DOI: 10.1111/j.1365-2796.2006.01622.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

1.  Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients.

Authors:  Julien Pottecher; Stéphane Deruddre; Jean-Louis Teboul; Jean-François Georger; Christian Laplace; Dan Benhamou; Eric Vicaut; Jacques Duranteau
Journal:  Intensive Care Med       Date:  2010-08-20       Impact factor: 17.440

2.  Vital organ tissue oxygenation after serial normovolemic exchange transfusion with HBOC-201 in anesthetized swine.

Authors:  William W Muir; Govindasamy Ilangovan; Jay L Zweier; Paula F Moon-Massat; Virginia T Rentko
Journal:  Shock       Date:  2011-06       Impact factor: 3.454

3.  Hemodilution causes glycocalyx shedding without affecting vascular endothelial barrier permeability in rats.

Authors:  Bülent Ergin; Philippe Guerci; Zühre Uz; Martin Westphal; Yasin Ince; Matthias Hilty; Can Ince
Journal:  J Clin Transl Res       Date:  2020-05-12

4.  Seasonal hematocrit variation and health risks in the adult population of Kinshasa, Democratic Republic of Congo.

Authors:  C Makena Hightower; Joyce D Hightower; Beatriz Y Salazar Vázquez; Marcos Intaglietta
Journal:  Vasc Health Risk Manag       Date:  2009-11-23

5.  An analytic study on the effect of alginate on the velocity profiles of blood in rectangular microchannels using microparticle image velocimetry.

Authors:  Katie L Pitts; Marianne Fenech
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

6.  Influence of serological factors and BMI on the blood pressure/hematocrit association in healthy young men and women.

Authors:  Beatriz Y Salazar Vázquez; Miguel A Salazar Vázquez; Adolfo Chávez-Negrete; Galileo Escobedo; Pedro Cabrales; Shankar Subramaniam; Marcos Intaglietta; Ruy Pérez-Tamayo
Journal:  Vasc Health Risk Manag       Date:  2014-05-06

7.  Perioperative predictors of early surgical revision and flap-related complications after microvascular free tissue transfer in head and neck reconstructions: a retrospective observational series.

Authors:  John-Patrik Burkhard; Jelena Pfister; Roland Giger; Markus Huber; Claudia Lädrach; Manuel Waser; Radu Olariu; Dominique Engel; Lukas M Löffel; Benoît Schaller; Patrick Y Wuethrich
Journal:  Clin Oral Investig       Date:  2021-03-08       Impact factor: 3.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.